Screening and identification of ssDNA aptamer for human GP73

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Du, Jingchun ^a   Hong, Jianming ^a   Xu, Chun ^a   Cai, Yuanyuan ^a   Xiang, Bo ^a   Zhou, Chengbo ^a   Xu, Xia ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; APTAMER; APTAMER A10 2; GOLGI PROTEIN 73; SINGLE STRANDED DNA; TUMOR MARKER; UNCLASSIFIED DRUG; GOLM1 PROTEIN, HUMAN; MEMBRANE PROTEIN;

AFFINITY CHROMATOGRAPHY; ANALYTIC METHOD; ARTICLE; CONTROLLED STUDY; DNA LIBRARY; DNA SEQUENCE; HUMAN; HUMAN CELL; IMMUNOGENICITY; LIVER CELL CARCINOMA; NICKLE ION AFFINITY CHROMATOGRAPHY; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PURIFICATION; SELEX TECHNIQUE; TUMOR CELL LINE; WESTERN BLOTTING; CARCINOMA, HEPATOCELLULAR; GENE EXPRESSION REGULATION; GENETICS; LIVER NEOPLASMS; SYSTEMATIC EVOLUTION OF LIGANDS BY EXPONENTIAL ENRICHMENT APTAMER TECHNIQUE;

ANTIBODIES; APTAMERS, NUCLEOTIDE; BIOMARKERS, TUMOR; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; DNA, SINGLE-STRANDED; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; MEMBRANE PROTEINS; SELEX APTAMER TECHNIQUE;

EID: 84947610190     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/610281     Document Type: Article

References (25)

1. A. Jemal, F. Bray, M. M. Center, J. Ferlay, E. Ward, and D. Forman, "Global cancer statistics," CA Cancer Journal for Clinicians, vol. 61, no. 2, pp. 69-90, 2011.
2. H. B. El-Serag, A. C. Mason, and C. Key, "Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States," Hepatology, vol. 33, no. 1, pp. 62-65, 2001.
3. J. Bruix and M. Sherman, "Management of hepatocellular carcinoma: an update," Hepatology, vol. 53, no. 3, pp. 1020-1022, 2011.
4. M. Schwartz, S. Roayaie, and M. Konstadoulakis, "Strategies for the management of hepatocellular carcinoma," Nature Clinical Practice Oncology, vol. 4, no. 7, pp. 424-432, 2007.
5. Y. Zhou, L. Li, L. Hu, and T. Peng, "Golgi phosphoprotein 2 (GOLPH2/GP73/GOLM1) interacts with secretory clusterin," Molecular Biology Reports, vol. 38, no. 3, pp. 1457-1462, 2011.
6. R. Masuzaki, S. J. Karp, and M. Omata, "New serum markers of hepatocellular carcinoma," Seminars in Oncology, vol. 39, no. 4, pp. 434-439, 2012.
7. M.-C. Ba, H. Long, Y.-Q. Tang, and S.-Z. Cui, "GP73 expression and its signifcance in the diagnosis of hepatocellular carcinoma: a review," International Journal of Clinical and Experimental Pathology, vol. 5, no. 9, pp. 874-881, 2012.
8. B. Hu, X. H. Tian, J. Sun, and X. J. Meng, "Evaluation of individual and combined applications of serum biomarkers for diagnosis of hepatocellular carcinoma: a meta-analysis," International Journal of Molecular Sciences, vol. 14, no. 12, pp. 23559-23580, 2013.
9. Y. Mao, H. Yang, H. Xu et al., "Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma," Gut, vol. 59, no. 12, pp. 1687-1693, 2010.
10. Y. X. Bao, Q. Cao, Y. Yang et al., "Expression and prognostic signifcance of Golgiglycoprotein73 (GP73) with Epithelial-Mesenchymal Transition (EMT) related molecules in Hepato-cellular Carcinoma (HCC)," Diagnostic Pathology, vol. 8, article 197, 2013.
11. C. Tuerk and L. Gold, "Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase," Science, vol. 249, no. 4968, pp. 505-510, 1990.
12. A. D. Ellington and J. W. Szostak, "Selection in vitro of single-stranded DNA molecules that fold into specifc ligand-binding structures," Nature, vol. 355, no. 6363, pp. 850-852, 1992.
13. P. R. Bouchard, R. M. Hutabarat, and K. M. Tompson, "Discovery and development of therapeutic aptamers," Annual Review of Pharmacology and Toxicology, vol. 50, pp. 237-257, 2010.
14. R. Nutiu and Y. Li, "Aptamers with fuorescence-signaling properties," Methods, vol. 37, no. 1, pp. 16-25, 2005.
15. M. Zuker, "Mfold web server for nucleic acid folding and hybridization prediction," Nucleic Acids Research, vol. 31, no. 13, pp. 3406-3415, 2003.
16. A. S. Lok, R. K. Sterling, J. E. Everhart et al., "Des-β-carboxy prothrombin and β-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma," Gastroenterology, vol. 138, no. 2, pp. 493-502, 2010.
17. C. M. Sturgeon, M. J. Dufy, B. R. Hofmann et al., "National academy of clinical biochemistry laboratory medicine practice guidelines for use of tumor markers in liver, bladder, cervical, and gastric cancers," Clinical Chemistry, vol. 56, no. 6, pp. e1-e48, 2010.
18. J. A. Marrero, P. R. Romano, O. Nikolaeva et al., "GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma," Journal of Hepatology, vol. 43, no. 6, pp. 1007-1012, 2005.
19. C. D. M. Witjes, S. M. van Aalten, E. W. Steyerberg et al., "Recently introduced biomarkers for screening of hepato-cellular carcinoma: a systematic review and meta-analysis," Hepatology International, vol. 7, no. 1, pp. 59-64, 2013.
20. J. Zhou, M. R. Battig, and Y. Wang, "Aptamer-based molecular recognition for biosensor development," Analytical and Bioan-alytical Chemistry, vol. 398, no. 6, pp. 2471-2480, 2010.
21. B. Soontornworajit and Y. Wang, "Nucleic acid aptamers for clinical diagnosis: cell detection and molecular imaging," Analytical and Bioanalytical Chemistry, vol. 399, no. 4, pp. 1591-1599, 2011.
22. B. I. Escudero-Abarca, S. H. Suh, M. D. Moore, H. P. Dwivedi, and L.-A. Jaykus, "Selection, characterization and application of nucleic acid aptamers for the capture and detection of human norovirus strains," PLoS ONE, vol. 9, no. 9, Article ID e106805, 2014.
23. F.-B. Wang, Y. Rong, M. Fang et al., "Recognition and capture of metastatic hepatocellular carcinoma cells using aptamer-conjugated quantum dots and magnetic particles," Biomaterials, vol. 34, no. 15, pp. 3816-3827, 2013.
24. R. D. Kladney, G. A. Bulla, L. Guo et al., "GP73, a novel Golgi-localized protein upregulated by viral infection," Gene, vol. 249, no. 1-2, pp. 53-65, 2000.
25. A. Zhang and B. Cao, "Generation and characterization of an anti-GP73 monoclonal antibody for immunoblotting and sandwich ELISA," The Journal of Biomedical Research, vol. 26, no. 6, pp. 467-473, 2012.